|
Sinoma Science & Technology Co.,Ltd. (002080.SZ) DCF Valuation
CN | Basic Materials | Chemicals | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Sinoma Science & Technology Co.,Ltd. (002080.SZ) Bundle
Enhance your investment strategies with the [Symbol] DCF Calculator! Explore authentic financial data from Sinoma Science & Technology Co.,Ltd., adjust growth forecasts and expenses, and instantly observe how these changes affect [Symbol]'s intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13,590.5 | 18,710.9 | 20,295.4 | 22,109.0 | 25,889.5 | 30,561.2 | 36,076.0 | 42,585.9 | 50,270.6 | 59,341.9 |
| Revenue Growth, % | 0 | 37.68 | 8.47 | 8.94 | 17.1 | 18.05 | 18.05 | 18.05 | 18.05 | 18.05 |
| EBITDA | 3,168.8 | 3,848.8 | 5,872.4 | 6,380.1 | 5,283.2 | 7,462.1 | 8,808.7 | 10,398.2 | 12,274.6 | 14,489.5 |
| EBITDA, % | 23.32 | 20.57 | 28.93 | 28.86 | 20.41 | 24.42 | 24.42 | 24.42 | 24.42 | 24.42 |
| Depreciation | 1,106.4 | 1,178.3 | 1,291.5 | 1,695.2 | 1,788.1 | 2,162.3 | 2,552.4 | 3,013.0 | 3,556.7 | 4,198.6 |
| Depreciation, % | 8.14 | 6.3 | 6.36 | 7.67 | 6.91 | 7.08 | 7.08 | 7.08 | 7.08 | 7.08 |
| EBIT | 2,062.4 | 2,670.6 | 4,580.8 | 4,684.9 | 3,495.1 | 5,299.9 | 6,256.2 | 7,385.2 | 8,717.8 | 10,290.9 |
| EBIT, % | 15.18 | 14.27 | 22.57 | 21.19 | 13.5 | 17.34 | 17.34 | 17.34 | 17.34 | 17.34 |
| Total Cash | 1,655.0 | 2,932.8 | 2,634.6 | 5,783.3 | 3,542.3 | 4,931.0 | 5,820.8 | 6,871.1 | 8,111.0 | 9,574.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6,150.9 | 7,673.7 | 8,738.3 | 10,269.4 | 12,304.1 | 13,648.7 | 16,111.6 | 19,019.0 | 22,450.9 | 26,502.2 |
| Account Receivables, % | 45.26 | 41.01 | 43.06 | 46.45 | 47.53 | 44.66 | 44.66 | 44.66 | 44.66 | 44.66 |
| Inventories | 2,151.4 | 2,109.4 | 2,250.3 | 3,177.5 | 3,905.0 | 4,134.8 | 4,880.9 | 5,761.6 | 6,801.3 | 8,028.6 |
| Inventories, % | 15.83 | 11.27 | 11.09 | 14.37 | 15.08 | 13.53 | 13.53 | 13.53 | 13.53 | 13.53 |
| Accounts Payable | 5,208.2 | 6,033.2 | 7,172.0 | 9,219.3 | 3,489.9 | 9,845.9 | 11,622.6 | 13,719.9 | 16,195.6 | 19,118.1 |
| Accounts Payable, % | 38.32 | 32.24 | 35.34 | 41.7 | 13.48 | 32.22 | 32.22 | 32.22 | 32.22 | 32.22 |
| Capital Expenditure | -2,176.7 | -2,705.8 | -1,803.5 | -4,537.0 | -7,765.3 | -5,493.6 | -6,484.9 | -7,655.2 | -9,036.5 | -10,667.2 |
| Capital Expenditure, % | -16.02 | -14.46 | -8.89 | -20.52 | -29.99 | -17.98 | -17.98 | -17.98 | -17.98 | -17.98 |
| Tax Rate, % | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 |
| EBITAT | 1,708.8 | 2,318.5 | 3,747.4 | 4,118.8 | 2,559.2 | 4,373.6 | 5,162.8 | 6,094.5 | 7,194.2 | 8,492.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,455.7 | 135.1 | 3,168.8 | 865.9 | -11,909.6 | 5,823.9 | -202.0 | -238.5 | -281.5 | -332.3 |
| WACC, % | 7.03 | 7.12 | 7.01 | 7.14 | 6.82 | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,619.6 | |||||||||
| Long Term Growth Rate, % | 1.00 | |||||||||
| Free cash flow (T + 1) | -336 | |||||||||
| Terminal Value | -5,571 | |||||||||
| Present Terminal Value | -3,967 | |||||||||
| Enterprise Value | 652 | |||||||||
| Net Debt | 17,201 | |||||||||
| Equity Value | -16,549 | |||||||||
| Diluted Shares Outstanding, MM | 1,678 | |||||||||
| Equity Value Per Share | -9.86 |
What You Will Receive
- Authentic Sinoma Financial Data: Pre-filled with Sinoma Science & Technology's (002080SZ) historical and projected figures for accurate analysis.
- Fully Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA %.
- Real-Time Calculations: Instantly view updates to Sinoma's intrinsic value as you make changes.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- User-Centric Design: Intuitive layout and clear guidance suitable for all skill levels.
Key Features
- Pre-Loaded Data: Sinoma Science & Technology Co., Ltd.'s historical financial statements and pre-populated forecasts.
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: Watch the intrinsic value of Sinoma Science & Technology Co., Ltd. (002080SZ) update in real time.
- Clear Visual Outputs: Interactive dashboard charts present valuation outcomes and essential metrics.
- Built for Accuracy: A robust tool designed for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Sinoma Science & Technology Co., Ltd. (002080SZ).
- Step 2: Examine the pre-filled financial data and forecasts provided for Sinoma.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: See the DCF model refresh in real-time as you update your assumptions.
- Step 5: Evaluate the results and apply the insights to your investment strategies.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and consultants in the industry.
- Accurate Data: Sinoma Science & Technology Co., Ltd. (002080SZ) historical and projected financials preloaded for enhanced precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Clear Results: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Guided instructions to navigate you through every step of the process.
Who Should Use This Product?
- Individual Investors: Make informed decisions regarding investments in Sinoma Science & Technology Co., Ltd. (002080SZ).
- Financial Analysts: Enhance valuation assessments with ready-to-apply financial models for Sinoma Science & Technology Co., Ltd. (002080SZ).
- Consultants: Provide accurate and timely valuation insights related to Sinoma Science & Technology Co., Ltd. (002080SZ) to clients.
- Business Owners: Gain a better understanding of how major corporations like Sinoma Science & Technology Co., Ltd. (002080SZ) are valued to inform your own strategies.
- Finance Students: Explore valuation methodologies using real-world data and case studies involving Sinoma Science & Technology Co., Ltd. (002080SZ).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Sinoma Science & Technology Co.,Ltd. (002080SZ), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for the Weighted Average Cost of Capital (WACC), featuring parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models detailing intrinsic value along with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (both annual and quarterly) to facilitate analysis.
- Key Ratios: Contains profitability, leverage, and efficiency ratios relevant to Sinoma Science & Technology Co.,Ltd. (002080SZ).
- Dashboard and Charts: A visual representation of valuation outputs and assumptions for straightforward result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.